Previous 10 | Next 10 |
Abiomed, Inc. (ABMD) Q1 2020 Earnings Conference Call August 01, 2019 08:00 AM ET` Company Participants Ingrid Goldberg - Director of Investor Relations Mike Minogue - Chairman, President & Chief Executive Officer Todd Trapp - Vice President & Chief Financial Officer C...
The following slide deck was published by Abiomed, Inc. in conjunction with their 2020 Q1 earnings Read more ...
Conformis (NASDAQ: CFMS ) -37% on softer revenue outlook . More news on: Conformis, Inc., Pluralsight, Inc., Whiting Petroleum Corporation, Stocks on the move, Read more ...
Abiomed ( ABMD ) Q2 results : Revenues: $207.7M (+15.4%). More news on: Abiomed, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
Abiomed (NASDAQ: ABMD ): Q1 Non-GAAP EPS of $1.00 beats by $0.01 ; GAAP EPS of $1.93 beats by $0.96 . More news on: Abiomed, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart recovery and support technologies, today reported first quarter fiscal 2020 revenue of $207.7 million, an increase of 15.4% compared to revenue of $180.0 million for the same period of fiscal 2019. Operating income was...
Abiomed, Inc . (NASDAQ: ABMD) announced that on Thursday, August 1, 2019, the Company will release financial results for the first quarter of fiscal 2020. The Company will host a conference call to discuss the results on Thursday, August 1, 2019, at 8:00 a.m. EDT. Michael R. Minogue, Chairma...
Today's top stories: S&P 3000; firing up the 'half pointers'; and French tax adds to trade tensions. If you are interested in listening to Wall Street Breakfast to start your day, look for us in the following places: iTunes (find all Seeking Alpha Podcasts here ) Stitcher...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify (click the highlighted links). The record bull market run capped another milestone on Wednesday as the S&P 500 jumped above 3,0...
Abiomed’s (NASDAQ:ABMD) Impella platform is being featured today at a Washington, D.C., event showcasing innovations in medical technology that improve healthcare for women. Abiomed’s participation supports its Women’s Initiative for Heart Recovery , which provid...
News, Short Squeeze, Breakout and More Instantly...
Abiomed (Nasdaq: ABMD) announces the United States Food and Drug Administration (FDA) has approved the version of Impella ECP that will be used in the Impella ECP Pivotal Trial, and the first two patients have been enrolled in the trial. Amir Kaki, MD, director of mechanical circulatory support...
Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400 Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400 PR Newswire NEW YORK , Dec. 19, 2022 /PRNewswire/ -- S&P MidCap 400 constituent...
Abiomed (Nasdaq: ABMD) announces the first three patients in the world have been treated with Impella RP Flex with SmartAssist, Abiomed’s newest heart pump for patients experiencing right heart failure. All three patients have now been successfully weaned off Impella support and two have...